TRPs represent a rapidly advancing therapeutic modality, offering precision treatment for various cancers and other diseases. However, the development and approval of TRPs globally require stringent adherence to regulatory standards for CMC.

This workshop will provide an in-depth analysis of the US regulatory framework governing CMC for TRPs, covering the critical requirements for ensuring product quality, manufacturing consistency, and regulatory compliance throughout the product lifecycle.

• CMC Regulatory Framework: Understand the key US regulations for CMC in TRPs, focusing on product quality and manufacturing standards
• Submission and Approval Process: Navigate the requirements for submitting CMC data to regulatory authorities, including current FDA guidelines
• Ensuring Compliance: Address challenges in demonstrating consistency and control over TRP manufacturing processes to meet regulatory expectations

–

Outcome – Whitepaper written for potential FDA guidelines which would help with overall TRP CMC process clarity.